Treatment of Newly Diagnosed Standard Risk Acute Lymphoblastic Leukemia in Children
Status:
Recruiting
Trial end date:
2033-12-31
Target enrollment:
Participant gender:
Summary
Aim of this study is to investigate the outcome of NGS MRD based risk stratified treatment
for standard risk acute lymphoblastic leukemia in children and adolescents.